Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

  1. Schmid, P.
  2. Cortes, J.
  3. Dent, R.
  4. Pusztai, L.
  5. McArthur, H.
  6. Kümmel, S.
  7. Bergh, J.
  8. Denkert, C.
  9. Park, Y.H.
  10. Hui, R.
  11. Harbeck, N.
  12. Takahashi, M.
  13. Untch, M.
  14. Fasching, P.A.
  15. Cardoso, F.
  16. Andersen, J.
  17. Patt, D.
  18. Danso, M.
  19. Ferreira, M.
  20. Mouret-Reynier, M.-A.
  21. Im, S.-A.
  22. Ahn, J.-H.
  23. Gion, M.
  24. Baron-Hay, S.
  25. Boileau, J.-F.
  26. Ding, Y.
  27. Tryfonidis, K.
  28. Aktan, G.
  29. Karantza, V.
  30. O'Shaughnessy, J.
  31. Show all authors +
Journal:
New England Journal of Medicine

ISSN: 1533-4406 0028-4793

Year of publication: 2022

Volume: 386

Issue: 6

Pages: 556-567

Type: Article

DOI: 10.1056/NEJMOA2112651 GOOGLE SCHOLAR